Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.39 |
| ▸ | USP2 | O75604 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SIK1 | P57059 | 2/20 | 0.34 |
| ▸ | SIK2 | Q9H0K1 | 2/20 | 0.34 |
| ▸ | SIK3 | Q9Y2K2 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18794906 | 0.80 | TDP1 (0.41) | TDP1ALOX15ALDH1A1LMNAMEN1 | |
| SCHEMBL28138220 | 0.77 | TDP1 (0.46) | TDP1ALOX15ALDH1A1LMNAMAPT | |
| SCHEMBL18794882 | 0.76 | IDO1 (0.36) | ALDH1A1MAPTTP53MEN1KMT2A | |
| SCHEMBL22560059 | 0.73 | USP2 (0.57) | TDP1ALOX15ALDH1A1LMNAMAPT | |
| SCHEMBL2162012 | 0.72 | TDP1 (0.69) | TDP1ALOX15ALDH1A1LMNAMAPT | |
| SCHEMBL22560057 | 0.71 | TDP1 (0.65) | TDP1ALOX15ALDH1A1LMNAMAPT | |
| SCHEMBL2163633 | 0.68 | LMNA (0.49) | TDP1ALOX15ALDH1A1LMNAMAPT | |
| SCHEMBL8918756 | 0.59 | ATM (0.50) | — | |
| SCHEMBL16065410 | 0.59 | ALDH1A1 (0.40) | ALDH1A1LMNAMAPTMAPK1KMT2A | |
| SCHEMBL17406960 | 0.59 | ALDH1A1 (0.40) | ALDH1A1LMNAMAPTMAPK1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3368517-B1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING BIOFILMS | UNIV LEUVEN KATH (BE) | 2023-07-05 | — | — | EP | disclosed |
| US-10807960-B2 | Compounds, compositions, and methods for controlling biofilms | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2020-10-20 | — | — | US | disclosed |
| US-20180305321-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR CONTROLLING BIOFILMS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2018-10-25 | — | — | US | disclosed |
| EP-3368517-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING BIOFILMS | Katholieke Universiteit Leuven (BE) | 2018-09-05 | — | — | EP | disclosed |
| WO-2017070755-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING BIOFILMS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2017-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180305321-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR CONTROLLING BIOFILMS | AADAC, TYR, HAAO | TDP1 1540/4885ALOX15 1509/4885ALDH1A1 1904/4885 |
| US-10807960-B2 | Compounds, compositions, and methods for controlling biofilms | AADAC, TYR, HAAO | TDP1 1540/4885ALOX15 1509/4885ALDH1A1 1904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.